S Laporte‐Simitsidis

Decision Analysis for Use of Platelet Aggregation Test, Carbon 14–Serotonin Release Assay, and Heparin–Platelet Factor 4 Enzyme-Linked Immunosorbent Assay for Diagnosis of Heparin-lnduced Thrombocytopenia

Claire Pouplard, Jean Amiral, Jeanne‐Yvonne Borg et al. · American Journal of Clinical Pathology · 1999 · 185 citations · Full text

Platelet Biology, Thrombosis, Thrombopoiesis +15

Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin)

Patrick Mismetti, S Laporte‐Simitsidis, Christelle Navarro et al. · Thrombosis and Haemostasis · 1998 · 96 citations

EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS

Bernard Tardy, B. Tardy-Poncet, L. Bara et al. · Thrombosis Research · 1996 · 33 citations

Thrombosis, Kinesiology, Aging +7

In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cells.

B. Perpoint, Marie‐Caroline Le Bousse‐Kerdilès, Denis Clay et al. · PubMed · 1995 · 26 citations

Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double‐blind randomized study

Bernard Tardy, Brigitte Tardy, S Laporte‐Simitsidis et al. · British Journal of Haematology · 1997 · 25 citations · Full text

Fibrinolysis Parameters, Pharmacotherapy, Rebound Phenomenon +18